You are here

Keytruda

Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain recurrent patients

Fierce Pharma

Thu, 05/15/25 - 10:25 pm

clinical trials

Merck begins construction on $1B Keytruda manufacturing facility in Delaware

Fierce Pharma

Wed, 04/30/25 - 10:54 am

drug manufacturing

Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer

BioSpace

Mon, 04/28/25 - 09:38 am

head and neck cancer

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through

Fierce Pharma

Thu, 04/24/25 - 09:17 pm

Trodelvy-Keytruda combo improves cancer trial outcomes

Investing.com

Mon, 04/21/25 - 11:11 am

Gilead Sciences

metastatic triple-negative breast cancer

Five Biggest Drug Face-Offs in Pharma History

BioSpace

Wed, 04/9/25 - 11:38 am

Bristol Myers Squibb

Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme

Fierce Pharma

Thu, 03/27/25 - 11:39 am

non-small cell lung cancer

Can Keytruda finally break into early head and neck cancer?

Pharmaphorum

Wed, 02/26/25 - 09:59 am

head and neck cancer

Merck expects Keytruda to face HHS price setting in 2026

MSN/Reuters

Tue, 02/25/25 - 10:45 pm

Inflation Reduction Act

FDA looks at Opdivo/Yervoy in first-line colorectal cancer

Pharmaphorum

Mon, 02/24/25 - 09:56 am

Bristol Myers Squibb

colorectal cancer

Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial

Fierce Pharma

Fri, 01/24/25 - 11:30 am

clinical trials

gastroesophageal adenocarcinoma

Merck is broadening its pipeline as Keytruda’s patent cliff looms

Pharma Voice

Tue, 01/14/25 - 09:53 am

BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer

Fierce Biotech

Tue, 12/10/24 - 11:42 am

clinical trials

Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer

Yahoo/Benzinga

Mon, 12/9/24 - 11:06 am

clinical trials

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Pharma Voice

Thu, 11/21/24 - 11:12 am

Merck says Keytruda injection on par with approved IV version in trial

CNBC

Tue, 11/19/24 - 11:17 am

Merck pays $588M for bispecific to defend Keytruda’s kingdom from emerging threat

Fierce Biotech

Thu, 11/14/24 - 10:07 am

bispecific antibodies

LaNova Medicines

Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead

Fierce Pharma

Thu, 10/31/24 - 10:50 pm

Moderna and Merck begin trial of mRNA-4157 and Keytruda combination for lung cancer

Clinical Trials Arena

Tue, 10/29/24 - 11:43 am

Moderna Therapeutics

clinical trials

non-small cell lung cancer

Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete

Xtalks

Thu, 10/10/24 - 10:02 am

Summit Therapeutics

non-small cell lung cancer

clinical trials

Pages